CPIG
AMPE

Chicago Partners Investment Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Chicago Partners Investment Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10
Closed -$1K – 612
2021
Q4 		$1K Buy
+10
New +$3.73K ﹤0.01% 568

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Chicago Partners Investment Group's AMPE Position: Q4 2022 in Review

Chicago Partners Investment Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 489 shares — an estimated $4K sold.

Chicago Partners Investment Group first reported a position in AMPE in Q3 2018 and held it in 17 quarters. The position peaked at $240K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Chicago Partners Investment Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 489 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $4K.
  • Chicago Partners Investment Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2018 and held it in 17 quarters.
  • Chicago Partners Investment Group's Ampio Pharmaceuticals Inc. position peaked at $240K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Chicago Partners Investment Group's 13F filing for Q4 2022, filed 9 Feb 2023.